A detailed history of Objective Capital Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Objective Capital Management, LLC holds 546 shares of VRTX stock, worth $222,866. This represents 0.15% of its overall portfolio holdings.

Number of Shares
546
Holding current value
$222,866
% of portfolio
0.15%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$460.0 - $505.78 $251,160 - $276,155
546 New
546 $253,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Objective Capital Management, LLC Portfolio

Follow Objective Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Objective Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Objective Capital Management, LLC with notifications on news.